These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 3435373

  • 1. Depot neuroleptic medication and serum levels by radioreceptor assay: prolactin concentration, electrocardiogram abnormalities and six-month outcome.
    Turbott J, Villiger J, Hunter L.
    Aust N Z J Psychiatry; 1987 Sep; 21(3):327-38. PubMed ID: 3435373
    [Abstract] [Full Text] [Related]

  • 2. Neuroleptic serum levels measured by radioreceptor assay in patients receiving intramuscular depot neuroleptics. Some preliminary findings.
    Turbott J, Villiger J, Hunter L.
    Br J Psychiatry; 1985 Apr; 146():439-42. PubMed ID: 4016448
    [Abstract] [Full Text] [Related]

  • 3. Serum neuroleptic levels and clinical outcome in schizophrenic patients treated with fluphenazine decanoate.
    Brown WA, Silver MA.
    J Clin Psychopharmacol; 1985 Jun; 5(3):143-7. PubMed ID: 3998204
    [Abstract] [Full Text] [Related]

  • 4. An open clinical trial with the long-acting neuroleptics flupenthixol decanoate and fluphenazine decanoate in the maintenance treatment of schizophrenia.
    Kong DS, Yeo SH.
    Pharmatherapeutica; 1989 Jun; 5(6):371-9. PubMed ID: 2687894
    [Abstract] [Full Text] [Related]

  • 5. Flupenthixol decanoate and fluphenazine decanoate in chronic schizophrenia.
    Kong DS, Yeo SH.
    Singapore Med J; 1985 Dec; 26(7):551-5. PubMed ID: 3834613
    [No Abstract] [Full Text] [Related]

  • 6. Comparative double-blind study of flupenthixol decanoate and fluphenazine decanoate in the treatment of patients relapsing in a schizophrenic symptomatology.
    Wistedt B, Ranta J.
    Acta Psychiatr Scand; 1983 Jun; 67(6):378-88. PubMed ID: 6349256
    [Abstract] [Full Text] [Related]

  • 7. A depot neuroleptic withdrawal study. A controlled study of the clinical effects of the withdrawal of depot fluphenazine decanoate and depot flupenthixol decanoate in chronic schizophrenic patients.
    Wistedt B.
    Acta Psychiatr Scand; 1981 Jul; 64(1):65-84. PubMed ID: 7032224
    [Abstract] [Full Text] [Related]

  • 8. Radioreceptor assay in checking serum concentration in long-term treatment with cis(z)-flupenthixol decanoate.
    Lipska B, Welbel L, Nurowska K, Szukalski B.
    Act Nerv Super (Praha); 1987 Dec; 29(4):270-3. PubMed ID: 3439426
    [Abstract] [Full Text] [Related]

  • 9. Further observations on the duration of depot neuroleptic maintenance therapy in schizophrenia.
    Johnson DA.
    Br J Psychiatry; 1979 Dec; 135():524-30. PubMed ID: 534806
    [No Abstract] [Full Text] [Related]

  • 10. Clinical and social comparison of fluphenazine decanoate and flupenthixol decanoate in the community maintenance therapy of schizophrenia.
    Kelly HB, Freeman HL, Banning B, Schiff AA.
    Int Pharmacopsychiatry; 1977 Dec; 12(1):54-64. PubMed ID: 406212
    [Abstract] [Full Text] [Related]

  • 11. Fluphenazine and flupenthixol decanoate in psychiatric outpatients practice.
    Coufal J, Novotný M.
    Act Nerv Super (Praha); 1981 Dec; 23(4):269-71. PubMed ID: 6121439
    [No Abstract] [Full Text] [Related]

  • 12. Neuroendocrine tests during treatment with neuroleptic drugs. II. The TRH test.
    Braddock LE, Blake IM.
    Br J Psychiatry; 1981 Nov; 139():404-7. PubMed ID: 6120732
    [Abstract] [Full Text] [Related]

  • 13. [Comparative study of the effects of fluphenazine-depot and flupenthixol-depot in the treatment of schizophrenic psychoses].
    Bilikiewicz A, Sep-Kowalikowa B.
    Psychiatr Pol; 1976 Nov; 10(4):359-66. PubMed ID: 981411
    [No Abstract] [Full Text] [Related]

  • 14. A double-blind comparison of flupenthixol decanoate and fluphenazine decanoate in the treatment of chronic schizophrenia.
    Pinto R, Bannerjee A, Ghosh N.
    Acta Psychiatr Scand; 1979 Oct; 60(4):313-22. PubMed ID: 390972
    [Abstract] [Full Text] [Related]

  • 15. Flupenthixol decanoate (fluanxol depot) in the treatment of chronic schizophrenic patients.
    Haider I.
    J Pak Med Assoc; 1985 Sep; 35(9):286-9. PubMed ID: 3934417
    [No Abstract] [Full Text] [Related]

  • 16. The discontinuance of maintenance neuroleptic therapy in chronic schizophrenic patients: drug and social consequences.
    Johnson DA, Pasterski G, Ludlow JM, Street K, Taylor RD.
    Acta Psychiatr Scand; 1983 May; 67(5):339-52. PubMed ID: 6135298
    [Abstract] [Full Text] [Related]

  • 17. [Studies on the long acting neuroleptic agent flupenthixol decanoate--a review (author's transl)].
    Sieberns S.
    Pharmakopsychiatr Neuropsychopharmakol; 1978 Jul; 11(4):186-98. PubMed ID: 674354
    [Abstract] [Full Text] [Related]

  • 18. Plasma levels of neuroleptic in patients receiving depot fluphenazine.
    Cohen BM, Waternaux C, Chouinard G, Sommer BR, Jones B.
    J Clin Psychopharmacol; 1985 Dec; 5(6):328-32. PubMed ID: 4066997
    [Abstract] [Full Text] [Related]

  • 19. Serum neuroleptic levels during reduced dose fluphenazine decanoate maintenance therapy.
    Heresco-Levy U, Greenberg D, Lerer B, Javitt DC, Brown WA.
    Isr J Psychiatry Relat Sci; 1997 Dec; 34(4):281-9. PubMed ID: 9409085
    [Abstract] [Full Text] [Related]

  • 20. Depot fluphenazine and flupenthixol in the treatment of stabilized schizophrenics. A double-blind comparative trial.
    Chowdhury ME, Chacon C.
    Compr Psychiatry; 1980 Dec; 21(2):135-9. PubMed ID: 6991205
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.